The use of new therapeutic strategies based on biological drugs should be considered for disease control [ 11], since PR antagonists, such as mifepristone, as an adjunctive treatment in breast cancer patients increase survival and reduce cancer recurrence [ 12]. The gene discussed is PGR; the disease is breast carcinoma.